SUSTAINED-RELEASE SYMPTOM-MODIFYING DRUGS FOR KNEE OSTEOARTHROSIS


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The investigation of 70 patients with knee osteoarthrosis and comorbid obesity demonstrated that the functional outcomes of 3-month intake of chondroitin sulfate, diacerein, and zinaxin were comparable.

Full Text

Restricted Access

References

  1. Bartels E., Bliddal H., Schendorff P. et al. Symptomatic efficacy and safety of diacerein in the treatment ofosteoarthritis: a meta-analysis of randomized placebo-controlled trials. Osteoarthritis Cartilage. - 2010; 18 (3): 289-96.
  2. Hochberg M., Chevalier X., Henrotin Y. et al. Symptom and structure modification in osteoarthritis with pharmaceutical-grade chondroitin sulfate: what's the evidence? // Curr. Med. Res. Upin. - 2013; 29 (3): 259-67.
  3. Leach M., Kumar S. The clinical effectiveness of Ginger (Zingiber officinale) in adults withosteoarthritis // Int. J Evid. Based Healthc. - 2008; 6 (3): 311-20.
  4. Красивина И.Г., Носкова А.С., Долгова Л.Н. Способ количественного определения мышечной слабости коленных суставов. Патент на изобретение №2289296. Зарегистрировано в Государственном реестре РФ 20.12.2006.
  5. Tobar N., Oliveira A., Guadagnini D. еt al. Diacerhein improves glucose tolerance and insulin sensitivity in mice on a high-fat diet // Endocrinology. - 2011; 152 (11): 4080-93.
  6. Ramos-Zavala et al. Effect of diacerein on insulin secretion and metabolic control in drug-naïve patients with type 2 diabetes: a randomized clinical trial // Diabetes Care. - 2011; 34: 1591-4.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2013 Russkiy Vrach Publishing House

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies